Ticker Scorecard - KPTI Basics Company: Karyopharm Therapeutics Inc. IPO Date: November 6, 2013 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $75.51M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.33% Avg Daily Range (30 D): $0.02 | 3.12% Avg Daily Range (90 D): $0.03 | 3.53% Institutional Daily Volume Avg Daily Volume: 1.04M Avg Daily Volume (30 D): .7M Avg Daily Volume (90 D): .77M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 202 Avg Trade Size (Sh.) (90 D): 300 Institutional Trades Total Inst.Trades: 2,414 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.55M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.88M Avg Closing Trade (30 D): $9.51M Avg Closing Trade (90 D): $9.51M Avg Closing Volume: 239.54K     News Nov 25, 2024 @ 4:00 PM Glioblastoma Multiforme Treatment Market Size to R... Source: Precedence Research Sep 5, 2024 @ 6:16 PM Down -12.14% in 4 Weeks, Here's Why Karyopharm The... Source: Zacks Jul 8, 2024 @ 5:02 PM Advanced Melanoma Clinical Trial Pipeline Analysis... Source: Delveinsight May 8, 2024 @ 8:45 PM Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Ca... Source: newsfeedback@fool.com (Motley Fool Transcribing) Feb 29, 2024 @ 11:15 PM Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Ca... Source: newsfeedback@fool.com (Motley Fool Transcribing) Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.74 $-.26 $.15 Diluted EPS $-1.05 $-.26 $-.2 Revenue $ 148.44M $ 38.78M $ 42.79M Gross Profit $ $ $ Net Income / Loss $ -87.48M $ -32.07M $ 23.79M Operating Income / Loss $ -125.97M $ -26.28M $ -28.12M Cost of Revenue $ $ $ Net Cash Flow $ 28.59M $ -11.94M $ 31.9M PE Ratio